Calliditas Therapeutics AB (CALT) Ownership - Who owns Calliditas Therapeutics AB?

24 days until earnings call

Profile

Industry
N/A
Address
Kungsbron 1, D5
Phone
+46 84113005
Employees
86
Web
https://www.calliditas.se

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.05B
P/E Ratio
N/A
Total Cash
810.32M
Projected Growth
N/A
Total Debt
1.02B
Revenue
1.31B
Risk (Beta)
1.65
Dividend Yield
N/A
Total Cash/Share
30.20
Total Debt/Equity
N/A
Revenue/Share
4.63 USD as % of share price

Fundamentals

CALT
Capitalization
1.05B
P/E Ratio
N/A
Risk (Beta)
1.65
Dividend Yield
N/A
Total Cash
810M
Total Cash/Share
30.20
Total Debt
1.02B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
4.63%
Revenue
1.31B
ROE
N/A
Book Value
120M
P/B Ratio
91.74
Cash Flow
N/A
Earnings
-19.58
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
2.69
Current Revenue Per Employee
1349228.20
Dividends Per Share - Security
N/A
EBITDA
-407.57M
Float
N/A
Float - Current
N/A
Gross Income Margin
95.26
Revenue To Assets
-31.09
Shares Held By Institutions
20.8M
Shares Outstanding - Current
26.8M
Total Liabilities
1.57B
Total Volume MTD
N/A
Value
-1
Gain YTD
50.676
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of pharmaceutical products for patients with niche indications

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Kungsbron 1, D5
Phone
+46 84113005
Employees
86
Web
https://www.calliditas.se